Investors in Clover Health (NASDAQ: CLOV) had a rough November. The healthcare company that is trying to revolutionize Medicare insurance with its Clover Assistant platform posted earnings for the third quarter and closed on a common stock offering in the month. The company's medical care ratio (MCR) for its Medicare patients, which measures costs as a percentage of premiums earned, stood at 102.5% in Q3, up from 86.7% last year.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting